Skip to main content
Top

Journal of Mammary Gland Biology and Neoplasia

Issue 2/2019

Content (8 Articles)

Metformin and Breast Cancer: Molecular Targets

J. Faria, G. Negalha, A. Azevedo, F. Martel

A Comparative Review of Mixed Mammary Tumors in Mammals

Eman S. A. Saad, Jacqueline S. Y. Lam, Awf A. Al-Khan, Mourad Tayebi, Michael J. Day, Samantha J. Richardson, Janine A. Danks

Open Access Breast Cancer

Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture

Eirikur Briem, Saevar Ingthorsson, Gunnhildur Asta Traustadottir, Bylgja Hilmarsdottir, Thorarinn Gudjonsson

A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

Zsófia Pénzváltó, Jane Qian Chen, Clifford G. Tepper, Ryan R. Davis, Matthew T. Silvestrini, Maxine Umeh-Garcia, Colleen Sweeney, Alexander D. Borowsky

Open Access

A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue

Helga Bergholtz, Tonje Gulbrandsen Lien, Giske Ursin, Marit Muri Holmen, Åslaug Helland, Therese Sørlie, Vilde Drageset Haakensen

Mammary Epithelial Cell Lineage Changes During Cow’s Life

Laurence Finot, Eric Chanat, Frederic Dessauge

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine